Literature DB >> 28351575

High stromal Foxp3-positive T cell number combined to tumor stage improved prognosis in head and neck squamous cell carcinoma.

Nadège Kindt1, Géraldine Descamps1, Imelda Seminerio1, Justine Bellier1, Jérôme R Lechien1, Quentin Mat1, Charles Pottier2, Philippe Delvenne2, Fabrice Journé3, Sven Saussez4.   

Abstract

OBJECTIVES: Head and neck squamous cell carcinomas (HNSCC), one of the most frequent cancers in the world, are largely infiltrated by inflammatory immune cells. Our aim was to evaluate the number of Foxp3+ T cells in HNSCC, reporting its prognostic power in comparison to other risk factors.
MATERIAL AND METHODS: Our clinical series was composed of 21 tumor-free peri-tumoral epithelia, 49 low grade dysplasia, 43 high grade dysplasia and 110 carcinoma samples including some cases with HPV infection. In vivo experiments were conducted on 80 C3H/HeN mice which were orthotopically injected with SCCVII CT, E7, E6 and E6/E7 cell lines.
RESULTS: Foxp3+ T cell infiltration increased with tumor progression from normal epithelia, dysplasia to carcinoma and the increase is more important in HPV+ patients than in negative ones. Animal experiments revealed that E7 oncoprotein expression was significantly associated with an increase in Foxp3+ T cell recruitment in tumor, a delay in tumor onset and improved animal survival. Univariate Cox regression analyses demonstrated that high Foxp3+ T cell number in stromal compartment is associated with longer patient recurrence-free and overall survivals. Foxp3+ T cell number improved the prognostic value of tumor stage. Multivariate analyses reported that stromal Foxp3+ T cell number is a strong prognostic factor independent of classical risk factors such as tobacco, alcohol, and HPV status.
CONCLUSION: Foxp3+ T cell number is a significant prognostic factor for HNSCC, improving the tumor stage, and that viral E7 may play a role in the Foxp3+ T cell infiltration to the tumor.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  E7; Foxp3; HNSCC; HPV; Prognosis

Mesh:

Substances:

Year:  2017        PMID: 28351575     DOI: 10.1016/j.oraloncology.2017.02.023

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  9 in total

1.  Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers.

Authors:  Sonia Furgiuele; Géraldine Descamps; Lorena Cascarano; Ambre Boucq; Christine Dubois; Fabrice Journe; Sven Saussez
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

2.  Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients.

Authors:  Sonia Furgiuele; Géraldine Descamps; Jerome R Lechien; Didier Dequanter; Fabrice Journe; Sven Saussez
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

3.  A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma.

Authors:  Wei Sun; Fan-Qin Wei; Wei-Jin Li; Jia-Wei Wei; Hua Zhong; Yi-Hui Wen; Wen-Bin Lei; Lin Chen; Hang Li; Han-Qing Lin; Muhammad Iqbal; Wei-Ping Wen
Journal:  Br J Cancer       Date:  2017-09-26       Impact factor: 7.640

4.  Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.

Authors:  Jerome R Lechien; Imelda Seminerio; Géraldine Descamps; Quentin Mat; Francois Mouawad; Stéphane Hans; Morbize Julieron; Didier Dequanter; Thibault Vanderhaegen; Fabrice Journe; Sven Saussez
Journal:  Cells       Date:  2019-09-10       Impact factor: 6.600

Review 5.  HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas.

Authors:  Jérôme R Lechien; Géraldine Descamps; Imelda Seminerio; Sonia Furgiuele; Didier Dequanter; Francois Mouawad; Cécile Badoual; Fabrice Journe; Sven Saussez
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

Review 6.  Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy.

Authors:  Ajaz A Bhat; Parvaiz Yousuf; Nissar A Wani; Arshi Rizwan; Shyam S Chauhan; Mushtaq A Siddiqi; Davide Bedognetti; Wael El-Rifai; Michael P Frenneaux; Surinder K Batra; Mohammad Haris; Muzafar A Macha
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

7.  A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic Cancer.

Authors:  Thomas Brouwer; Marieke Ijsselsteijn; Jan Oosting; Dina Ruano; Manon van der Ploeg; Frederike Dijk; Bert Bonsing; Arantza Fariña; Hans Morreau; Alexander Vahrmeijer; Noel de Miranda
Journal:  Cancers (Basel)       Date:  2022-08-10       Impact factor: 6.575

8.  Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.

Authors:  Joon Young Hur; Bo Mi Ku; Sehhoon Park; Hyun Ae Jung; Se-Hoon Lee; Myung-Ju Ahn
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

9.  High infiltration of CD68+ macrophages is associated with poor prognoses of head and neck squamous cell carcinoma patients and is influenced by human papillomavirus.

Authors:  Imelda Seminerio; Nadège Kindt; Géraldine Descamps; Justine Bellier; Jérôme R Lechien; Quentin Mat; Charles Pottier; Fabrice Journé; Sven Saussez
Journal:  Oncotarget       Date:  2018-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.